Identification of patients with dilated phase of hypertrophic cardiomyopathy using a convolutional neural network applied to multiple, dual, and single lead electrocardiograms
Source check: Source checked. Not independent scientific confirmation.
Finding: A CNN applied to ECGs identified dilated-phase hypertrophic cardiomyopathy in a retrospective single-center cohort; in the held-out test data the eight-lead AUC was 0.929 and V5 single-lead AUC 0.953. This is a specific diagnostic-validation result, not evidence of clinical deployment. PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.
Technology: PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.
- Test and result
- PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.
- Limitation / still unknown
- PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10160501/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.